Advanced Closed-Loop Neurostimulation System with Real-Time Impedance Monitoring for Enhanced Electrode Longevity
This neurostimulation technology introduces a sophisticated implantable stimulator system that utilizes real-time impedance measurement and adaptive charge-balanced, asymmetric biphasic pulses to enhance therapeutic efficacy, electrode longevity, and patient safety.
Description
The technology consists of a stimulator system featuring an implantable electrode and electronic circuitry that includes a current source and a control system. The system is designed to deliver current-controlled stimulation (CCS) using an asymmetric, biphasic pulse where the first phase (e.g., a square wave) is followed by a second phase with a gradually decaying amplitude. This decaying amplitude, often achieved via an exponential decay from a discharging capacitor, is dynamically adjusted based on real-time impedance measurements at the electrode-tissue interface.The control system employs an algorithm based on an RC circuit model to determine precise parameters for the second phase, ensuring charge balance between the two phases. By utilizing a processor and memory system to analyze impedance data at multiple frequencies, the stimulator can maintain a charge discrepancy of less than 5%, effectively mitigating the irreversible electrochemical reactions that typically lead to electrode corrosion and tissue injury.
Applications
- Chronic pain management through targeted neurostimulation therapies.- Implantable medical devices requiring safe, long-term neural stimulation with minimized electrode wear.
- Neuromodulation treatments for neurological disorders necessitating precise current delivery despite variable tissue impedance.
- Research applications involving controlled electrical stimulation of neural tissue with emphasis on electrode durability and safety.
- Design and development of advanced bioelectronic interfaces incorporating real-time impedance feedback and adaptive stimulation waveforms.
Advantages
- Precise Current Delivery: The use of current-controlled stimulation ensures that therapeutic currents remain consistent irrespective of changes in tissue impedance, thereby enhancing treatment reliability.- Charge Balancing with Asymmetric Biphasic Pulses: By implementing a biphasic pulse where the second phase decays gradually, the system effectively neutralizes net charge, preventing electrode material degradation and mitigating risk of tissue damage.
- Impedance Monitoring and Adaptive Control: Continuous measurement of electrode-tissue impedance allows dynamic adjustment of stimulation parameters, optimizing both efficacy and safety.
- Advanced Circuitry Integration: The inclusion of processors, memory, and DACs facilitates complex algorithms for charge calculation and waveform generation, enabling sophisticated and customizable stimulation protocols.
- Demonstrated Electrode Longevity: Experimental validation underscores the system’s capacity to maintain electrode integrity under chronic operation, promising longer implant service life.
- User Interface and Programmability: Provides medical practitioners the ability to monitor, modify, and tailor stimulation parameters to patient-specific needs efficiently.
